Ryan Cassaday, MD

Challenges and opportunities for improvement in the practical management of adults with acute lymphoblastic leukemia - PubMed As our approaches to the management of adults with acute lymphoblastic leukemia (ALL) have become more effective, they have introduced new administrative complexities. These include challenges pertaining to medication administration and financial implications of treatment choices. Because approximat …

Treating adults with #ALL is very complex. To help clinicians and researchers recognize common challenges, I offer this paper. Based on years of treating this disease @fredhutch.org, @uwmedicine.bsky.social, and community partners.

pubmed.ncbi.nlm.nih.gov/41056518/

#MedSky #HemOnc

The early 🐦 gets the 🪱. And by 🪱, I mean DISCOUNT. 💰🤑

Register by 6/17, then humblebrag about how much you saved on this amazing #HemeOnc review course. Featuring faculty from @uwmedicine.bsky.social & @fredhutch.bsky.social

web.cvent.com/event/59cb41c0…

And now with the right handles 🤦‍♂️

@uwmedicine.bsky.social and @fredhutch.bsky.social

Fin.

📣 Announcement!

Registration for our 16th Annual Comprehensive Hematology and Oncology Review Course is now available! Oct. 6-10 the Bell Harbor ICC on the shores of Elliott Bay in Downtown Seattle.

Great @UWMedicine and @fredhutch speakers. And me. 😁#cme

web.cvent.com/event/59cb41c0…

Blinatumomab-Based Regimens Enhance and Refine the B-ALL Treatment Paradigm: With Ryan Cassaday, MD Ryan Cassaday, MD, discussed insights from trials investigating blinatumomab in patients with B-ALL that were reported at the 2024 ASH Annual Meeting.

Thanks to staff of #OncLiveOnAir for the chance to discuss abstracts on ALL from #ASH24. @uwmedicine.bsky.social @fredhutch.bsky.social

www.onclive.com/view/blinatu...

Great seeing Katie Lai here in Seattle for Best of @ash.hematology.org who spoke on #AML. If you’re ever in the neighborhood, the bar at the Fairmont Olympic Hotel is lovely!